Eligible, But Probably Obvious: Prometheus Patents Critiqued In Government's Amicus Brief

The Solicitor General tells the Supreme Court that Prometheus' patents on a process for determining the proper dose of thiopurine drugs should have included "concrete treatment steps."

More from Archive

More from Pink Sheet